Evidence map›Paper›PMID 40643354›Full record

Trial reportClinical pharmacology in drug development2025

Pharmacokinetic and Bioequivalence Evaluation of Two Sitagliptin Tablets With Different Salts in Healthy Subjects.

Usok Hyun, Seongnam Chu, Sungyun Kim, Jung-Ki Hong, Taeyoung Kim, In-Soo Yoon, Jung-Jin Kim, Hyun-Jong Cho

Abstract readRandomized Controlled TrialClinical Trial, Phase I
In one paragraph

Trial report in Clinical pharmacology in drug development, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Usok HyunDepartment of Pharmacy, Kangwon National University, Chuncheon, Republic of Korea.
Seongnam ChuDepartment of Pharmacy, Kangwon National University, Chuncheon, Republic of Korea.
Sungyun KimDepartment of Pharmacy, Kangwon National University, Chuncheon, Republic of Korea.
Jung-Ki HongDepartment of Manufacturing Pharmacy, College of Pharmacy and Research Institute for Drug Development, Pusan National University, Busan, Republic of Korea.
Taeyoung KimDepartment of Manufacturing Pharmacy, College of Pharmacy and Research Institute for Drug Development, Pusan National University, Busan, Republic of Korea.
In-Soo YoonDepartment of Manufacturing Pharmacy, College of Pharmacy and Research Institute for Drug Development, Pusan National University, Busan, Republic of Korea.
Jung-Jin KimDepartment of Pharmaceutical Engineering, College of Food & Pharmaceutical Engineering, Mokpo National University, Muan, Jeonnam, Republic of Korea.
Hyun-Jong ChoDepartment of Pharmacy, Kangwon National University, Chuncheon, Republic of Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The objective of the current study was to evaluate the rate and extent of absorption of a test formulation (sitagliptin hydrochloride) and a reference formulation (sitagliptin phosphate). An open-label, randomized, single-dose, single-center, 2-sequence, 2-period, and cross-over phase 1 study was implemented to assess the pharmacokinetic bioequivalence of the test and reference formulations containing a single dose of sitagliptin 100 mg in 32 healthy volunteers under fasting conditions. The differences between the test and reference formulations in terms of the area under the curve from dosing to the time of the last measured concentration (AUC

Indexed as

Dipeptidyl-Peptidase IV InhibitorsSitagliptin PhosphateAdministration, OralAdultArea Under CurveCross-Over StudiesFastingHealthy VolunteersHumansMaleMiddle AgedSaltsTabletsTherapeutic EquivalencyYoung AdultDipeptidyl-Peptidase IV InhibitorsSaltsSitagliptin PhosphateTabletsbioequivalenceclinical pharmacokineticspreclinical studysitagliptin hydrochloridesitagliptin phosphate

Identifiers

PMID40643354
PMCPMC12486195

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.